P50 Sensory Gating Deficit in Obese Individuals
Abstract
Objective: Obesity may cause cognitive dysfunctions such as attention, processing speed, memory, and executive functioning. However, little is known about how obesity can affect cognitive functions in obese individuals. Sensory gating shows the early pre-attention period in information processing and is accepted to be the result of the integration of multi-step procedures that can be tested with the double click P50 paradigm. The aim of this study is to investigate changes in cognitive functions with sensory gating in obese individuals.
Methods: A total of 31 obese individuals and age- and sex-matched healthy 24 control subjects were included in the study. The latencies and amplitude P50 waves were measured in the healthy controls and obese individuals. Also the P50 sensory gating was calculated.
Results: We found a significant difference between the obese group and controls regarding the amplitude of the first P50 wave (p<0.048). The obese group showed reduced P50 sensory gating as compared to controls (p<0.004).
Conclusion: The findings suggest that obese individuals have a sensory gating abnormality seems to be a result of cholinergic dysfunction. This results may help explain congnitive impairment in obese individuals.
References
Flegal KM, Troiano RP. Changes in the distribution of body mass index of adults and children in the US population. Int J Obes Relat Metab Disord 2000;24:807-18.
Aronne, LJ. Epidemiology, morbidity, and treatment of overweight and obesity. Journal of Clinical Psychiatry 2001;62: 13–22.
Fergenbaum JH, Bruce S, Lou W, Hanley AJ, GreenwoodC, Young TK. Obesity and lowered cognitive performance in a Canadian first nation population. Obesity 2009;17:1957–63.
Lokken KL, Boeka AG, Austin HM, Gunstad J, Harmon CM. Evidence of executive dysfunction in extremely obese adolescents: a pilot study. Surg Obes Relat Dis 2009:5;547–52.
Battersby C, Hartley K, Feltcher AE. et al. Cognitive function in hypertension: A community based study. Journal of Human Hypertension. 1993;7:117–23.
Manschot SM, Brands AM, Van der Grond J. et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106-13.
Ostrosky-Solis F, Mendoza VU, Ardila A. Neuropsychological profile of patients with primary systemic hypertension. InternationalJournal of Neuroscience 2001;11: 159–72.
Salorio CF, White DA, Piccirillo J, Duntley SP, & Uhles ML. Learning, memory, and executive control in individuals with obstructive sleep apnea syndrome. Journal of Clinical and Experimental Neuropsychology 2002;24: 93–100.
Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Comprehensive Psychiatry 2007;48: 57–61.
Whitmer RA, Gunderson EP, Barrett-Connor E. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. British Medical Journal 2005; 330(7504):1360.
Boutros NN, Belger A. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry 1999; 45:917-22.
Davies PL, Chang WP, Gavin WJ. Maturation of sensory gating performance in children with and without sensory processing disorders. International Journal of Psychophysiology. 2009;72:187-97.
David Potter, Ann Summerfelt, James Gold, andRobert W. Buchanan. Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients withSchizophrenia. Schizophr Bull 2006;32:692-700.
Wan L, Friedman BH, Boutros NN, Crawford HJ. P50 sensory gating and attentional performance. Int J Psychophysiol 2008;67:91-100.
Thomas C, Vom Berg I, Rupp A et al. P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function. Neurobiol Aging 2010; 31:416-24.
Jo YH, Talmage DA, Role LW. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 2002;53:618-32
Goodman CB, Soliman KF. Altered brain cholinergic enzymes activity in the genetically obese rat.Experienta1991;15;47:833-5.
First MB, Gibbon M, Spitzer JB, Williams JB, Benjamin L 1997 User's guide for the structured clinical interview for DSM-IV axis II personality disorders: SCID-II. Washington, DC: Amer Psychiatric Pub Inc.
Ghisolfi ES, Margis R, Becker J, Zanardo AP, Strimitzer IM, Lara DR. Impaired P50 sensory gating in post-traumatic stress disorder secondary to urban violence. Int J Psychophysiol 2004;51:209-14.
G.A. Light, M.A. Geyer, B.A. Clementz, K.S. Cadenhead, D.L. Braff. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.American Journal of Psychiatry 2000;157:767–71.
Harvey J. Leptin: A diverse regulator of neuronal function. Journal of Neurochemistry 2007; 100:307–13.
Wilson, C. J., Finch, C. E., & Harvey, J. C. Cytokines and cognition—The case for a head-to-toe inflammatory paradigm. Journal of the American Geriatrics Society. 2002; 20: 2041–56.
Luchsinger J.A, Gustafson D.R. Adiposity,type2diabetes, and Alzheimer’sdisease. J. AlzheimersDis 2009;16: 693-704.
Diano S.,HorvathTL. Anticonvulsant effects of leptin in epilepsy. J.Clin. Invest 2008;118: 26-8.
Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, etal. Brain structure an do besity. Hum.BrainMapp 2010; 31: 353–64.
Han C, Jo SA, Seo JA, Kim BG, Kim NH, Jo I, etal. Adiposity parameters and cognitive function in the elderly: application of "Jolly Fat" hypothesis to cognition.Arch Gerontol Geriatr 2009;49:133-8.
Gustafson DR. Adiposity and cognitive decline: underlying mechanisms. J.Alzheimers Dis. 2012;30 Suppl 2:S97-112.
Gustafson DR, Luchsinger JA. High adiposity: risk factor for dementia and Alzheimer’s disease? Alzheimers Res Ther 2013; 5:57.
Chan JS, Yan JH, Payne VG. The Impact of Obesity and Exercise on Cognitive Aging Front Aging Neurosci 2013; 5: 97.
Gunstad J, Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive Dysfunction and working memory in otherwise healthy adults. Comprehensive Psychiatry 2007;48: 57–61.
Leland DS, Pineda JA.Effects of food-related stimuli on visual spatial attention in fasting and nonfasting normal subjects: Behavior and electrophysiology Clinical neurophysiology.2006;117:67-84.
Nijs IMT, Franken IHA, Muris P. Food-related Stroop interference in obese and normal-weight individuals: Behavioral and electrophysiological indices. Eating behaviors 2010;11:258-65.
Johannesen JK, Kieffaber PD, O'Donnell BF, Shekhar A, Evans JD, Hetrick WP . Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia.Schizophr Res 2005; 15;78:269-84.
Reese NB, Garcia-Rill E, Skinnerb RD, et al. Auditory input to the pedunculopontine nucleus: I. Evoked potentials,Brain Res. Bull. 1995;257-64.
Bickford-Wimer PC, Nagamoto H, Johnson R. et al. Auditory sensory gating in hippocampal neurons: a model system in the rat. Biological Psychiatry 1990;27:183–92.
Beck P, Urbano FJ, Williams DK, et al. Effects of leptin on pedunculopontine nucleus (PPN) neurons. J Neural Transm 2013;120:1027-38
Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Research 1992;587:130–6.
Elmquist JK, Elias CF, Saper CB. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 1999;22:221-32.
Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998; 92:437-40.
Hayashi M, Miyata R, Tanuma N. Decrease in acetylcholinergic neurons in the pedunculopontine tegmental nucleus in a patient with Prader-Willi syndrome. Neuropathology 2011;31:280-5.
